Karen L. Smith - May 16, 2022 Form 4 Insider Report for Talaris Therapeutics, Inc. (TALS)

Role
Director
Signature
/s/ Mary Kay Fenton, as Attorney-in-Fact
Stock symbol
TALS
Transactions as of
May 16, 2022
Transactions value $
$0
Form type
4
Date filed
5/17/2022, 06:15 PM
Previous filing
Mar 1, 2022
Next filing
May 23, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TALS Stock Option (Right to Buy) Award $0 +29K $0.00 29K May 16, 2022 Common Stock 29K $6.54 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares underlying this option shall vest in three equal installments from the date of grant.